Histiocytic cytophagic panniculitis which developed during interferon-α therapy

Internal Medicine

Volumn 35, Issue 2, 1996, Pages 115-118

  Kuno, Momoyo ^a   Mimori, Akio ^a   Fujii, Takeshi ^a   Takeda, Akira ^a   Masuyama, Junichi ^a   Yoshio, Taku ^a   Minota, Seiji ^a   Kano, Shogo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

chronic hepatitis C; side effect

Indexed keywords

RECOMBINANT ALPHA INTERFERON;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; EYELID; FEMALE; HEPATITIS C; HISTIOCYTIC SKIN DISEASE; HUMAN; PANNICULITIS; SKIN EDEMA;

EID: 0029940635     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.115     Document Type: Article

References (13)

1. McSweeney EN, Giles FJ, Worman CP, et al. Recombinant interferon alpha 2a in the treatment of patients with early stage B chronic lymphocytic leukemia. Br J Haematol 85: 77, 1993.
2. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol 89: 399, 1994.
3. Mayet WJ, Hess G, Gerken, et al. Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10: 24, 1989.
4. Ueno Y, Sohma T. Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma. Ann Intern Med 117: 266, 1992.
5. Chazerain P, Meyer O, Kahn MF. Rheumatoid arthritis-like disease after alpha-interferon therapy. Ann Intern Med 116: 427, 1992.
6. Tlaymat A, Leventhal B, Sakarcan A, Kashima H, Monteiro C. Systemic lupus erythematosus in a child receiving long-term interferon therapy. J Pediatr 120: 429, 1992.
7. Hirashima N, Mizokami M, Orito E, et al. Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment. Intern Med 33: 300, 1994.
8. Winkelmann RK, Bowie EJW. Hemorrhagic diathesis associated with benign histiocytic cytophagic panniculitis and systemic histiocytosis. Arch Intern Med 140: 1460, 1980.
9. Crotty CP, Winkelmann RK. Cytophagic histiocytic panniculitis with fever, cytopenia, liver failure, and terminal hemorrhagic diathesis J Am Acad Dermatol 4: 181, 1981.
10. Rcdali RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome. A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44: 993, 1979.
11. Egeler RM, Schmitz L, Sonneveld P, Mannival C, Nesbit ME. Malignant histiocytosis: a reassessment of cases formerly classified as histiocytic neoplasms and review of the literature. Med Pediatr Oncol 25: 1, 1995.
12. Sen GC, Lengyel P. The interferon system. J Biol Chem 267: 5017, 1992.
13. Jewell AP, Yong KL, Worman CP, Tsakona CP, Giles FJ, Goldstone AH. Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL. Br J Haematol 86:441, 1994.